Melinta Therapeutics (United States)
Melinta Therapeutics is an American biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Melinta Therapeutics (United States), United States, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
68%
Total
Publications
163
Total Open
Publications
111
Total
Citations
4.7K
Open Access
Percentage
68%
Total
Publications
163
Total Open
Publications
111
Total
Citations
4.7K
Breakdown
Publisher Open
23%
Both
38%
Other Platform Open
7%
Closed
32%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 51%
51
Hybrid 30%
30
No Guarantees 19%
19
Other Platform Open
Domain 88%
65
Public 27%
20
Institution 8%
6
Preprint 3%
2
Other Internet 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 65 |
Europe PMC | Domain | 40 |
Semantic Scholar | Public | 20 |
DOI | Other Internet | 10 |
Radboud University - Radboud Repository | Institution | 2 |
bioRxiv | Preprint | 2 |
University of Udine - Institutional Research Information System | Institution | 1 |
University of Massachusetts Amherst - ScholarWorks@UMassAmherst | Institution | 1 |
Universitat Pompeu Fabra - Repositori digital de la UPF | Institution | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |